NASDAQ:ISRG - Intuitive Surgical Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $718.28
  • Forecasted Upside: 7.67 %
  • Number of Analysts: 22
  • Breakdown:
  • 3 Sell Ratings
  • 7 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
$667.08
▼ -19.2 (-2.80%)
1 month | 3 months | 12 months
Get New Intuitive Surgical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ISRG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ISRG

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$718.28
▲ +7.67% Upside Potential
This price target is based on 22 analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $718.28, with a high forecast of $815.00 and a low forecast of $365.00. The average price target represents a 7.67% upside from the last price of $667.08.
Hold
The current consensus among 22 polled investment analysts is to hold stock in Intuitive Surgical.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 11 buy ratings
  • 5 hold ratings
  • 1 sell ratings
5/9/2019
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/7/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/5/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 2 sell ratings
2/3/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 7 hold ratings
  • 4 sell ratings
5/3/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 7 hold ratings
  • 3 sell ratings
8/1/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 8 hold ratings
  • 3 sell ratings
9/30/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 7 hold ratings
  • 3 sell ratings
10/30/2020

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 7 hold ratings
  • 3 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/16/2020SVB LeerinkBoost Price TargetMarket Perform$690.00 ➝ $725.00High
i
10/16/2020JPMorgan Chase & Co.Boost Price TargetOverweight$765.00 ➝ $785.00High
i
10/16/2020Stifel NicolausBoost Price TargetBuy$725.00 ➝ $815.00High
i
10/16/2020Wells Fargo & CompanyBoost Price TargetOverweight$727.00 ➝ $815.00High
i
10/16/2020Morgan StanleyBoost Price TargetOverweight$735.00 ➝ $785.00High
i
10/16/2020Piper SandlerBoost Price TargetNeutral$595.00 ➝ $680.00High
i
10/15/2020BTIG ResearchReiterated RatingHoldHigh
i
10/12/2020Raymond JamesBoost Price TargetOutperform$725.00 ➝ $800.00High
i
9/28/2020ArgusInitiated CoverageBuy$775.00Medium
i
9/14/2020BTIG ResearchReiterated RatingHoldLow
i
9/11/2020Wolfe ResearchInitiated CoverageOutperform$789.00Low
i
9/8/2020Bank of AmericaDowngradeBuy ➝ Neutral$725.00 ➝ $760.00High
i
9/1/2020Robert W. BairdInitiated CoverageNeutral$700.00High
i
8/14/2020SVB LeerinkBoost Price TargetMarket Perform$650.00 ➝ $690.00Low
i
Rating by Richard Newitter at SVB Leerink LLC
8/3/2020BTIG ResearchReiterated RatingHoldLow
i
7/22/2020JPMorgan Chase & Co.Boost Price TargetOverweight$600.00 ➝ $700.00High
i
Rating by Tycho Peterson at JPMorgan Chase & Co.
7/22/2020UBS GroupBoost Price TargetNeutral$565.00 ➝ $670.00Medium
i
7/22/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$500.00 ➝ $600.00Medium
i
7/22/2020Morgan StanleyBoost Price TargetOverweight$602.00 ➝ $735.00Medium
i
7/22/2020Canaccord GenuityBoost Price TargetBuy$562.00 ➝ $725.00Medium
i
7/22/2020SVB LeerinkBoost Price TargetMarket Perform$590.00 ➝ $650.00Medium
i
Rating by Richard Newitter at SVB Leerink LLC
7/22/2020Raymond JamesBoost Price TargetOutperform$600.00 ➝ $725.00Low
i
7/22/2020Piper SandlerBoost Price TargetNeutral$510.00 ➝ $595.00Medium
i
Rating by Adam Maeder at Piper Sandler
7/22/2020Wells Fargo & CompanyBoost Price TargetOverweight$632.00 ➝ $727.00Medium
i
7/20/2020Sanford C. BernsteinBoost Price TargetOutperform$625.00 ➝ $725.00Medium
i
Rating by Lee Hambright at Sanford C. Bernstein
7/20/2020Stifel NicolausBoost Price TargetBuy$575.00 ➝ $715.00Medium
i
7/15/2020SVB LeerinkBoost Price TargetMarket Perform$535.00 ➝ $590.00High
i
Rating by Richard Newitter at SVB Leerink LLC
7/13/2020Sanford C. BernsteinReiterated RatingBuy$625.00High
i
Rating by Lee Hambright at Sanford C. Bernstein
6/18/2020JPMorgan Chase & Co.Boost Price TargetOverweight$565.00 ➝ $600.00Low
i
Rating by Tycho Peterson at JPMorgan Chase & Co.
6/16/2020OTR GlobalDowngradePositiveLow
i
6/4/2020Wells Fargo & CompanyBoost Price TargetOverweight$561.00 ➝ $632.00Medium
i
4/28/2020OppenheimerReiterated RatingSell$365.00High
i
Rating by Suraj Kalia at Oppenheimer Holdings Inc.
4/28/2020Piper SandlerDowngradeOverweight ➝ Neutral$570.00 ➝ $510.00Medium
i
Rating by Adam Maeder at Piper Sandler
4/19/2020Evercore ISIDowngradeIn-Line ➝ UnderperformLow
i
4/17/2020UBS GroupLower Price TargetNeutral$620.00 ➝ $565.00Medium
i
4/17/2020CfraDowngradeHold ➝ SellMedium
i
4/17/2020Piper SandlerLower Price Target$633.00 ➝ $570.00High
i
Rating by Adam Maeder at Piper Sandler
4/17/2020Wells Fargo & CompanyBoost Price TargetOverweight$555.00 ➝ $561.00Medium
i
Rating by Larry Biegelsen at Wells Fargo & Company
4/17/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$595.00 ➝ $500.00Low
i
4/17/2020Stifel NicolausBoost Price TargetBuy$425.00 ➝ $575.00Low
i
4/17/2020Canaccord GenuityLower Price TargetAccumulate ➝ Buy$655.00 ➝ $562.00Low
i
Rating by Jason Mills at Canaccord Genuity
4/17/2020SVB LeerinkDowngradeOutperform ➝ Market Perform$575.00 ➝ $535.00Medium
i
4/17/2020BTIG ResearchReiterated RatingHoldHigh
i
4/13/2020Raymond JamesLower Price TargetOutperform$660.00 ➝ $600.00Low
i
Rating by Lawrence Keusch at Raymond James
4/9/2020Bank of AmericaReiterated RatingBuy$650.00Low
i
4/9/2020Evercore ISIDowngradeIn-Line ➝ UnderperformLow
i
4/8/2020Piper SandlerReiterated RatingBuy$633.00High
i
Rating by Adam Maeder at Piper Sandler
4/2/2020Wells Fargo & CompanyLower Price TargetOverweight$655.00 ➝ $545.00Medium
i
Rating by Larry Biegelsen at Wells Fargo & Company
4/1/2020The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyMedium
i
4/1/2020OppenheimerDowngradeMarket Perform ➝ Underperform$365.00High
i
Rating by Suraj Kalia at Oppenheimer Holdings Inc.
3/27/2020Morgan StanleyLower Price TargetOverweight$670.00 ➝ $622.00Low
i
Rating by David Lewis at Morgan Stanley
3/24/2020Stifel NicolausLower Price TargetBuy$665.00 ➝ $425.00High
i
3/17/2020JPMorgan Chase & Co.Lower Price TargetOverweight$665.00 ➝ $575.00High
i
Rating by Tycho Peterson at JPMorgan Chase & Co.
2/12/2020The Goldman Sachs GroupInitiated CoverageBuy$725.00Medium
i
1/27/2020Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$610.00 ➝ $595.00Low
i
1/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight$575.00 ➝ $665.00High
i
1/24/2020Raymond JamesBoost Price TargetOutperform$615.00 ➝ $660.00High
i
Rating by Lawrence Keusch at Raymond James
1/24/2020Canaccord GenuityReiterated RatingBuyHigh
i
Rating by Jason Mills at Canaccord Genuity
1/10/2020Canaccord GenuityReiterated RatingBuy$655.00Low
i
Rating by Jason Mills at Canaccord Genuity
1/10/2020UBS GroupBoost Price TargetNeutral$590.00 ➝ $620.00Medium
i
Rating by Matthew Taylor at UBS Group AG
1/10/2020Cantor FitzgeraldReiterated RatingOverweight$620.00 ➝ $690.00Medium
i
Rating by Craig Bijou at Cantor Fitzgerald
12/17/2019Morgan StanleyBoost Price TargetOverweight$620.00 ➝ $670.00Low
i
Rating by David Lewis at Morgan Stanley
12/9/2019Wells Fargo & CompanyReiterated RatingOverweight$620.00 ➝ $655.00High
i
Rating by Larry Biegelsen at Wells Fargo & Company
11/20/2019OppenheimerInitiated CoverageMarket PerformLow
i
10/18/2019Piper Jaffray CompaniesSet Price TargetBuy$633.00Low
i
Rating by JP McKim at Piper Jaffray Companies
10/18/2019Royal Bank of CanadaSet Price TargetHold$570.00Low
i
Rating by Brandon Henry at Royal Bank of Canada
10/18/2019Morgan StanleySet Price TargetBuy$620.00Low
i
Rating by David Lewis at Morgan Stanley
10/18/2019Wells Fargo & CompanySet Price TargetBuy$620.00Low
i
Rating by Larry Biegelsen at Wells Fargo & Company
10/18/2019Raymond JamesBoost Price TargetBuy$610.00 ➝ $625.00Low
i
10/18/2019UBS GroupBoost Price TargetNeutral$560.00 ➝ $590.00High
i
Rating by Matthew Taylor at UBS Group AG
9/13/2019Redburn PartnersInitiated CoverageBuyLow
i
7/19/2019Northland SecuritiesSet Price TargetSell$375.00Low
i
Rating by Suraj Kalia at Northland Securities
7/19/2019Cantor FitzgeraldSet Price TargetBuy$620.00Low
i
Rating by Craig Bijou at Cantor Fitzgerald
7/19/2019Morgan StanleySet Price TargetBuy$620.00Low
i
Rating by David Lewis at Morgan Stanley
7/19/2019UBS GroupSet Price TargetHold$560.00Low
i
Rating by Matthew Taylor at UBS Group AG
7/19/2019Canaccord GenuityReiterated RatingBuy ➝ Buy$575.00 ➝ $610.00Medium
i
7/19/2019Piper Jaffray CompaniesBoost Price TargetOverweight$610.00 ➝ $633.00Medium
i
5/22/2019Piper Jaffray CompaniesUpgradeOverweight$610.00Low
i
5/14/2019CitigroupLower Price TargetBuy$611.00 ➝ $575.00Low
i
4/23/2019CitigroupLower Price TargetBuy ➝ Buy$684.00 ➝ $611.00Medium
i
4/22/2019Raymond JamesLower Price TargetOutperform ➝ Outperform$630.00 ➝ $610.00High
i
4/22/2019Canaccord GenuityReiterated RatingBuy ➝ Buy$610.00 ➝ $575.00Low
i
4/21/2019BTIG ResearchReiterated RatingHoldLow
i
4/18/2019Piper Jaffray CompaniesReiterated RatingOverweight$610.00Low
i
4/4/2019Cantor FitzgeraldSet Price TargetBuy$620.00Low
i
Rating by Craig Bijou at Cantor Fitzgerald
4/1/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$630.00 ➝ $630.00Low
i
4/1/2019Raymond JamesBoost Price TargetOutperform ➝ Outperform$600.00 ➝ $630.00Low
i
2/28/2019Royal Bank of CanadaSet Price TargetHold$560.00High
i
Rating by Brandon Henry at Royal Bank of Canada
1/25/2019Cantor FitzgeraldReiterated RatingBuy$620.00Low
i
1/25/2019Stifel NicolausLower Price TargetBuy$600.00 ➝ $570.00Low
i
1/10/2019Northland SecuritiesReiterated RatingSell$375.00Low
i
1/2/2019CitigroupLower Price TargetBuy ➝ Buy$601.00 ➝ $560.00Low
i
11/29/2018CitigroupLower Price TargetBuy ➝ Buy$606.00 ➝ $601.00Low
i
11/27/2018UBS GroupInitiated CoverageNeutral$540.00High
i
10/31/2018Piper Jaffray CompaniesBoost Price TargetOverweight$613.00 ➝ $625.00Low
i
10/21/2018BTIG ResearchReiterated RatingHoldMedium
i
10/19/2018Royal Bank of CanadaReiterated RatingHold$560.00High
i
Rating by Brandon Henry at Royal Bank of Canada
10/19/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$620.00 ➝ $630.00High
i
10/19/2018Piper Jaffray CompaniesBoost Price TargetOverweight$613.00High
i
10/19/2018Canaccord GenuityUpgradeHold ➝ Buy$550.00 ➝ $610.00High
i
10/19/2018Cantor FitzgeraldReiterated RatingBuy$620.00High
i
10/11/2018Morgan StanleyBoost Price TargetOverweight$575.00 ➝ $600.00Low
i
10/9/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$600.00High
i
9/12/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$575.00 ➝ $635.00Medium
i
8/2/2018CitigroupBoost Price TargetBuy ➝ Buy$561.00 ➝ $592.00Low
i
7/22/2018BTIG ResearchReiterated RatingHoldLow
i
7/20/2018Northland SecuritiesReiterated RatingSell$300.00Medium
i
7/20/2018The Goldman Sachs GroupBoost Price TargetBuy$540.00 ➝ $630.00High
i
7/20/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$515.00 ➝ $600.00High
i
7/20/2018Morgan StanleyReiterated RatingOverweight ➝ Overweight$535.00 ➝ $575.00High
i
7/20/2018Royal Bank of CanadaSet Price TargetHold$550.00High
i
Rating by Brandon Henry at Royal Bank of Canada
7/20/2018JPMorgan Chase & Co.Reiterated RatingOverweight$575.00High
i
7/20/2018Cantor FitzgeraldReiterated RatingBuy$510.00 ➝ $620.00High
i
7/17/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$510.00 ➝ $600.00Low
i
6/27/2018Sanford C. BernsteinInitiated CoverageOutperform$560.00Medium
i
6/1/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$525.00 ➝ $535.00High
i
4/18/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$465.00 ➝ $510.00Low
i
4/18/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$410.00 ➝ $430.00High
i
4/18/2018Royal Bank of CanadaSet Price TargetHold$460.00High
i
Rating by Brandon Henry at Royal Bank of Canada
4/18/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$500.00 ➝ $525.00High
i
4/18/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$480.00 ➝ $515.00High
i
4/18/2018SVB LeerinkReiterated RatingOutperform$475.00 ➝ $510.00High
i
4/18/2018Cantor FitzgeraldBoost Price TargetOverweight$510.00High
i
4/18/2018Piper Jaffray CompaniesBoost Price TargetNeutral$460.00High
i
2/6/2018CitigroupLower Price TargetBuy ➝ Buy$507.00Medium
i
1/26/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$450.00 ➝ $500.00Low
i
1/26/2018Royal Bank of CanadaBoost Price TargetSector Perform$430.00High
i
Rating by Brandon Henry at Royal Bank of Canada
1/26/2018Canaccord GenuityReiterated RatingHold ➝ Hold$380.00 ➝ $410.00High
i
1/26/2018Cantor FitzgeraldReiterated RatingBuy$490.00High
i
1/26/2018CitigroupReiterated RatingBuy$531.00High
i
1/26/2018BarclaysBoost Price TargetOverweight ➝ Overweight$475.00High
i
1/26/2018Piper Jaffray CompaniesReiterated RatingHoldHigh
i
1/25/2018Stifel NicolausReiterated RatingBuy ➝ Buy$400.00 ➝ $480.00High
i
1/18/2018SVB LeerinkReiterated RatingOutperform ➝ Outperform$390.00 ➝ $475.00Low
i
1/11/2018BarclaysReiterated RatingOverweight ➝ Overweight$465.00Medium
i
1/5/2018Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$410.00Low
i
1/3/2018Evercore ISIInitiated CoverageIn ➝ In-Line$380.00High
i
11/18/2017The Goldman Sachs GroupReiterated RatingBuyN/A
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
10/20/2017BarclaysReiterated RatingOverweightN/A
i
10/17/2017Canaccord GenuityReiterated RatingHoldN/A
i
10/16/2017Wells Fargo & CompanyReiterated RatingBuyN/A
i
10/10/2017WedbushReiterated RatingBuyN/A
i
9/25/2017WedbushReiterated RatingOutperform$353.33Low
i
9/5/2017Morgan StanleyReiterated RatingOverweightHigh
i
Rating by Jonathan Demchick at Morgan Stanley
9/1/2017Royal Bank of CanadaReiterated RatingHold$333.33N/A
i
7/26/2017Canaccord GenuityReiterated RatingHold$290.01 ➝ $333.33Low
i
7/25/2017Morgan StanleyReiterated RatingOverweight$316.68 ➝ $356.67Low
i
Rating by Jonathan Demchick at Morgan Stanley
7/24/2017CitigroupReiterated RatingBuy$305.67 ➝ $359.34Low
i
7/22/2017Stifel NicolausReiterated RatingBuy$283.32 ➝ $366.66Medium
i
7/21/2017Royal Bank of CanadaReiterated RatingHold$333.33Medium
i
7/21/2017JPMorgan Chase & Co.Reiterated RatingOverweight$350.01High
i
7/21/2017BarclaysBoost Price TargetOverweight$290.01 ➝ $333.33High
i
7/21/2017Cantor FitzgeraldReiterated RatingHold$350.01High
i
7/18/2017Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$266.67 ➝ $316.68Low
i
7/12/2017Wells Fargo & CompanyReiterated RatingOutperform$333.33 ➝ $350.01Low
i
7/11/2017Canaccord GenuityReiterated RatingHold$290.01Low
i
7/5/2017SVB LeerinkReiterated RatingOutperformMedium
i
6/29/2017Cantor FitzgeraldInitiated CoverageNeutral ➝ Neutral$333.33Low
i
6/15/2017BTIG ResearchReiterated RatingHoldLow
i
6/1/2017Bank of AmericaReiterated RatingBuy$333.33Low
i
Rating by Bob Hopkins at Bank of America Co.
5/30/2017Canaccord GenuityDowngradeBuy ➝ Hold$290.01Low
i
5/25/2017Wells Fargo & CompanyReiterated RatingOutperform$333.33Low
i
5/22/2017Morgan StanleySet Price TargetOverweight$279.99 ➝ $316.68Low
i
5/16/2017The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$333.33Medium
i
4/25/2017Jefferies Financial GroupReiterated RatingBuy$225.00Low
i
4/24/2017WedbushBoost Price TargetOutperform$278.34 ➝ $291.66Low
i
4/22/2017SVB LeerinkReiterated RatingOutperform$279.99 ➝ $283.32Low
i
4/22/2017CitigroupReiterated RatingBuy$273.33 ➝ $305.67Low
i
4/20/2017BTIG ResearchReiterated RatingHoldLow
i
4/19/2017Stifel NicolausBoost Price TargetBuy$266.67 ➝ $283.32Low
i
4/19/2017Evercore ISIBoost Price TargetIn-Line$249.99 ➝ $261.66Low
i
4/19/2017Canaccord GenuityReiterated RatingBuy$266.67 ➝ $290.01Medium
i
4/19/2017WedbushBoost Price TargetOutperform ➝ Outperform$266.67 ➝ $278.34High
i
4/19/2017BarclaysReiterated RatingBuy$266.67 ➝ $276.66High
i
4/17/2017Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$240.00 ➝ $256.68Medium
i
3/26/2017BarclaysReiterated RatingBuy$266.67Medium
i
3/24/2017Canaccord GenuityReiterated RatingBuy$266.67Low
i
2/14/2017Bank of AmericaSet Price TargetBuy$256.68 ➝ $266.67N/A
i
1/25/2017Canaccord GenuityReiterated RatingBuyN/A
i
1/14/2017WedbushReiterated RatingOutperform$266.67N/A
i
1/4/2017Evercore ISIDowngradeBuy ➝ Hold$230.01N/A
i
10/21/2016BarclaysReiterated RatingOverweight$249.99 ➝ $253.32N/A
i
Rating by Matthew Taylor at Barclays PLC
10/19/2016Canaccord GenuityBoost Price TargetBuy$249.99 ➝ $266.67N/A
i
Rating by Jason Mills at Canaccord Genuity
10/19/2016WedbushReiterated RatingOutperform$261.66 ➝ $251.67N/A
i
10/19/2016Royal Bank of CanadaSet Price TargetHold$249.99 ➝ $253.32N/A
i
10/19/2016Royal Bank of CanadaBoost Price TargetSector Perform$250.00 ➝ $253.32N/A
i
10/13/2016Wells Fargo & CompanyInitiated CoverageOutperformN/A
i
9/20/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Tycho Peterson at JPMorgan Chase & Co.
9/20/2016BTIG ResearchReiterated RatingHoldN/A
i
Rating by Sean Lavin at BTIG Research
9/19/2016SVB LeerinkReiterated RatingOutperform$260.01N/A
i
8/26/2016Raymond JamesInitiated CoverageOutperformN/A
i
7/21/2016Northland SecuritiesDowngrade$200.00N/A
i
7/20/2016Evercore ISIReiterated RatingBuy$250.00 ➝ $258.33N/A
i
Rating by Vijay Kumar at Evercore ISI
7/20/2016CitigroupBoost Price TargetBuy$241.00 ➝ $259.68N/A
i
Rating by Amit Hazan at Citigroup Inc.
7/20/2016BarclaysBoost Price TargetOverweight$230.00 ➝ $250.00N/A
i
Rating by Matthew Taylor at Barclays PLC
7/20/2016Piper Jaffray CompaniesReiterated RatingNeutral$203.34 ➝ $233.34N/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
7/20/2016BTIG ResearchReiterated RatingNeutralN/A
i
Rating by Sean Lavin at BTIG Research
7/20/2016Canaccord GenuityBoost Price TargetBuy$233.34 ➝ $250.00N/A
i
Rating by Jason Mills at Canaccord Genuity
7/20/2016WedbushBoost Price TargetOutperform$238.32 ➝ $251.67N/A
i
7/20/2016Stifel NicolausBoost Price TargetBuy$233.34 ➝ $266.67N/A
i
6/22/2016Bank of AmericaReiterated RatingBuyN/A
i
Rating by Bob Hopkins at Bank of America Co.
6/18/2016BarclaysReiterated RatingBuyN/A
i
Rating by Matthew Taylor at Barclays PLC
6/15/2016Piper Jaffray CompaniesReiterated RatingNeutral$203.34N/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
6/7/2016Canaccord GenuityReiterated RatingBuy$233.34N/A
i
Rating by Jason Mills at Canaccord Genuity
6/6/2016Bank of AmericaReiterated RatingBuyN/A
i
Rating by Bob Hopkins at Bank of America Co.
6/2/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Tycho Peterson at JPMorgan Chase & Co.
6/2/2016CitigroupReiterated RatingBuyN/A
i
Rating by Amit Hazan at Citigroup Inc.
6/2/2016The Goldman Sachs GroupDowngradeBuy ➝ Neutral$211.00 ➝ $224.67N/A
i
4/20/2016SVB LeerinkBoost Price TargetOutperform$233.34 ➝ $236.67N/A
i
Rating by Richard Newitter at SVB Leerink LLC
4/20/2016Piper Jaffray CompaniesBoost Price TargetNeutral$183.33 ➝ $203.34N/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
4/20/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by David Lewis at Morgan Stanley
4/20/2016Bank of AmericaReiterated RatingBuy$213.33 ➝ $250.00N/A
i
4/20/2016Evercore ISIBoost Price TargetBuy$225.00 ➝ $233.34N/A
i
Rating by Vijay Kumar at Evercore ISI
4/20/2016Stifel NicolausBoost Price TargetBuy$213.33 ➝ $233.34N/A
i
4/20/2016WedbushReiterated RatingOutperform$226.68N/A
i
4/20/2016Canaccord GenuityReiterated RatingBuy$221.34 ➝ $233.34N/A
i
Rating by Jason Mills at Canaccord Genuity
4/20/2016Royal Bank of CanadaBoost Price TargetSector Perform$203.34 ➝ $213.33N/A
i
4/14/2016Sterne Agee CRTReiterated RatingNeutralN/A
i
4/12/2016SVB LeerinkBoost Price TargetOutperform$213.33 ➝ $233.34N/A
i
Rating by Richard Newitter at SVB Leerink LLC
4/8/2016The Goldman Sachs GroupBoost Price Target$211.00 ➝ $221.34N/A
i
4/1/2016BTIG ResearchDowngradeBuy ➝ Neutral$200.00N/A
i
3/31/2016Piper Jaffray CompaniesReiterated RatingHold$183.33N/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
3/25/2016Bank of AmericaReiterated RatingBuy$213.33N/A
i
3/17/2016Canaccord GenuityInitiated CoverageBuy$221.34N/A
i
Rating by Jason Mills at Canaccord Genuity
3/14/2016Bank of AmericaReiterated RatingBuy$213.33N/A
i
2/29/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by Jason Mills at Canaccord Genuity
1/25/2016BarclaysReiterated RatingOverweight$216.67N/A
i
1/24/2016Piper Jaffray CompaniesReiterated RatingHoldN/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
1/22/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Richard Newitter at SVB Leerink LLC
1/22/2016BTIG ResearchReiterated RatingBuy$191.67 ➝ $200.00N/A
i
1/22/2016WedbushReiterated RatingOutperform$226.67N/A
i
Rating by Tao Levy at Wedbush
1/22/2016Evercore ISIReiterated RatingBuy$200.00 ➝ $206.67N/A
i
Rating by Vijay Kumar at Evercore ISI
1/22/2016Canaccord GenuityReiterated RatingBuy$208.32N/A
i
Rating by Jason Mills at Canaccord Genuity
1/22/2016William BlairReiterated RatingBuyN/A
i
1/22/2016Stifel NicolausBoost Price TargetBuy$200.00 ➝ $213.33N/A
i
1/14/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by Jason Mills at Canaccord Genuity
1/14/2016SVB LeerinkBoost Price TargetOutperform$200.00 ➝ $213.33N/A
i
Rating by Richard Newitter at SVB Leerink LLC
1/13/2016Evercore ISIReiterated RatingBuy$200.00N/A
i
Rating by Vijay Kumar at Evercore ISI
1/13/2016Piper Jaffray CompaniesReiterated RatingHoldN/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
1/11/2016WedbushBoost Price TargetOutperform$216.66 ➝ $226.67N/A
i
Rating by Tao Levy at Wedbush
1/7/2016BTIG ResearchReiterated RatingBuy$191.67N/A
i
1/7/2016Royal Bank of CanadaBoost Price TargetSector Perform$188.34 ➝ $203.34N/A
i
1/4/2016Morgan StanleyUpgradeEqual Weight ➝ Overweight$166.67 ➝ $216.67N/A
i
12/9/2015SVB LeerinkReiterated RatingOutperform$200.00N/A
i
Rating by Richard Newitter at SVB Leerink LLC
11/13/2015The Goldman Sachs GroupLower Price Target$210.00 ➝ $208.67N/A
i
11/12/2015CitigroupInitiated CoverageBuy$200.34N/A
i
11/11/2015BTIG ResearchReiterated RatingBuy$191.67N/A
i
Rating by Sean Lavin at BTIG Research
(Data available from 10/31/2015 forward)
Intuitive Surgical logo
Intuitive Surgical, Inc., together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; and EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $667.08
$653.00
$686.00

50 Day Range

MA: $707.85
$641.95
$755.67

52 Week Range

Now: $667.08
$360.50
$778.83

Volume

996,415 shs

Average Volume

763,757 shs

Market Capitalization

$78.42 billion

P/E Ratio

75.98

Dividend Yield

N/A

Beta

0.94